Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Role of thrombotic risk factors in end-stage renal disease.

Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis - 1 Apr 2010

Tripathi Gaurav, Sankhwar Satya Narayan, Sharma Raj Kumar, Baburaj Vinod Pandirikkal, Agrawal Suraksha

Abstract excerpt

INTRODUCTION: Genetic polymorphisms that are found among factors of the coagulation cascade are factor V leiden mutation (FVL), prothrombin (PT), and methylenetetrahydrofolate reductase (MTHFR), reported for thrombotic complications. We have investigated the associations of these gene polymorphisms in patients with end-stage renal disease (ESRD). METHODS: We genotyped 258 patients for FV G1691A, PT G20210A, and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Factor V
Share to Folic Acid

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Homocysteine

Share to Hyperhomocysteinemia

Share to Kidney Failure, Chronic

Share to Prothrombin

Share to Thrombophilia

Share to Vitamin B 12

Source

Identifiers

PMID: 19520684
DOI: 10.1177/1076029609335911

Genes

MTHFR

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Role of thrombotic risk factors in end-stage renal disease.PMID 19520684Read ↗

Role of Inherited Thrombophilia Risk Factors in Patients with CKD-5 Receiving Haemodialysis.Semantic proximity Read ↗

Methylenetetrahydrofolate reductase gene polymorphisms in essential hypertension relation: with the development of hypertensive end-stage renal disease.Semantic proximity Read ↗

Correlations of MTHFR 677C>T polymorphism with cardiovascular disease in patients with end-stage renal disease: a meta-analysis.Semantic proximity Read ↗

MTHFR A1298C polymorphism is associated with cardiovascular risk in end stage renal disease in North Indians.Semantic proximity Read ↗

Hemostatic Factors, APOL1 Risk Variants, and the Risk of ESRD in the Atherosclerosis Risk in Communities Study.Semantic proximity Read ↗

Endothelial nitric oxide synthetase, methylenetetrahydrofolate reductase polymorphisms, and cardiovascular complications in Tunisian patients with nondiabetic renal disease.Semantic proximity Read ↗

Inherited Risk Factors of Thromboembolic Events in Patients with Primary Nephrotic Syndrome.Semantic proximity Read ↗

Influence of 5,10-methylenetetrahydrofolate reductase gene polymorphism on plasma homocysteine concentration in patients with end-stage renal disease.Semantic proximity Read ↗

High cysteine levels in renal transplant recipients: relationship with hyperhomocysteinemia and 5,10-MTHFR polymorphism.Semantic proximity Read ↗

Methylenetetrahydrofolate reductase (MTHFR) polymorphism A1298C (Glu429Ala) predicts decline in renal function over time in the African-American Study of Kidney Disease and Hypertension (AASK) Trial and Veterans Affairs Hypertension Cohort (VAHC).Semantic proximity Read ↗

An MTHFR variant, homocysteine, and cardiovascular comorbidity in renal disease.Semantic proximity Read ↗

The common mutations C677T and A1298C in the human methylenetetrahydrofolate reductase gene are associated with hyperhomocysteinemia and cardiovascular disease in hemodialysis patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.